Collect Product
Product Details
- ProductSizeAmountActiveMax® Human CD7 μBeads, premium grade (for cells)2.5 mg2.5×10⁷ beadsActiveMax® Human CD7 μBeads, premium grade (for cells)10 mg (2.5 mg×4)1.0×10⁸ beads
Product Show
This product can be directly isolated using conventional column-free magnetic stand (eg. Cat. MB-01/ MB-02/ MB-03/ MB-04). Please note that due to its micron-scale size, it is not compatible with commercially available column-based (M/D/L) magnetic separation systems.
Product Description
ActiveMax® Human CD7 μBeads, premium grade (for cells) are uniform, superparamagnetic beads of 5.5 µm in diameter immobilized with Human CD7 protein expressed from human 293 cells (HEK293) and contains AA Ala 26 - Pro 180 (Accession # P09564-1).
ActiveMax® Human CD7 μBeads, premium grade (for cells) are produced under sterile manufacturing conditions (ISO 5), and no animal- or human-derived components are used throughout the production process. It is produced under our rigorous quality control system that includes a comprehensive set of tests including sterility and endotoxin tests.Application
ActiveMax® Human CD7 μBeads, premium grade (for cells) are designed to stimulate in vitro CD7-specific CAR-T cells or UCAR-T cells, similar to the tumor cell lines that express human CD7 antigen. It can be used as follows:
Evaluating the characteristics of CAR-T cells or UCAR-T cells.
In vitro expansion of CD7-specific CAR-T cells or UCAR-T cells.
In vitro enrichment of CD7-specific CAR-T cells or UCAR-T cells.Reconstitution
See Certificate of Analysis (CoA) for detailed instruction.
Storage
This product is stable in storage under the following conditions: -20˚C for 12 months in lyophilized state. -70°C for 3 months under sterile conditions after reconstitution.
Please protect from light and avoid repeated freeze-thaw cycles.Immediate use after reconstitution is highly recommended.
Sterility
Negative
Endotoxin
Less than 0.002 EU per μg by the LAL method / rFC method.
Mycoplasma
Negative
Important Note
This product is for research use only and not intended for therapeutic or in vivo diagnostic use.
Formulation
Lyophilized in PBS with 0.1% HSA，pH 7.4. Trehalose is added as protectant before lyophilization.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
FACS Data
Assay of human CD7 protein on the μBeads surface by Flow cytometry. ActiveMax® Human CD7 μBeads, premium grade (for cells) (Cat. No. MBS-C005) were stained with anti-human CD7 antibody, and then followed by FITC anti-human IgG Fc antibody and analyzed by flow cytometry.
Protocol
User Reviews Publish Comment
FAQ
- product
Can lyophilized proteins remain stable during room-temperature shipping or temporary room-temperature exposure?
In general, lyophilized proteins remain stable during room-temperature shipping or temporary exposure to room-temperature conditions.
Many ACROBiosystems recombinant proteins are supplied in lyophilized (freeze-dried) form. The lyophilization process effectively removes moisture from the product, helping reduce degradation-related reactions and improve protein stability during transportation and storage.
To evaluate the stability of lyophilized proteins under normal temperature conditions, ACROBiosystems conducted a stability study on 11 representative lyophilized protein products at 37°C. The study demonstrated that these proteins maintained good quality stability after storage at 37°C for approximately 20 days. Based on these validation results, temporary room-temperature exposure during shipping or handling is generally not expected to have a significant impact on product quality or downstream application performance.
To ensure optimal long-term stability, products should be stored according to the storage conditions specified in the product Certificate of Analysis (COA) upon receipt.
Supporting Document
Frontier Progress
Drug Development Progress- English Name：
T-cell antigen CD7
- Category：
- Listed Drugs Count：
0 Details
- Clinical Drugs Count：
32 Details
- Highest R&D Stage：
Phase 2 Clinical
Contact Us
Drug Candidate Licensing
